Name | Number of supported studies | Average coverage | |
---|---|---|---|
epithelial cell | 6 studies | 25% ± 6% | |
goblet cell | 5 studies | 21% ± 3% | |
hepatocyte | 5 studies | 27% ± 11% | |
GABAergic neuron | 3 studies | 20% ± 2% | |
glutamatergic neuron | 3 studies | 22% ± 2% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 18% ± 3% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 3660.69 | 245 / 245 | 99% | 132.32 | 499 / 502 |
liver | 100% | 6454.62 | 226 / 226 | 96% | 45.44 | 391 / 406 |
esophagus | 100% | 1270.28 | 1445 / 1445 | 96% | 11.31 | 176 / 183 |
stomach | 100% | 1119.40 | 359 / 359 | 94% | 15.23 | 269 / 286 |
intestine | 100% | 3690.56 | 966 / 966 | 93% | 16.25 | 489 / 527 |
breast | 100% | 1665.10 | 459 / 459 | 92% | 21.44 | 1026 / 1118 |
kidney | 100% | 3466.71 | 89 / 89 | 91% | 18.29 | 823 / 901 |
lung | 99% | 1094.57 | 575 / 578 | 89% | 8.40 | 1023 / 1155 |
bladder | 100% | 2361.19 | 21 / 21 | 82% | 10.64 | 411 / 504 |
ovary | 100% | 1157.87 | 180 / 180 | 79% | 6.34 | 339 / 430 |
skin | 100% | 1450.42 | 1809 / 1809 | 77% | 5.88 | 365 / 472 |
pancreas | 98% | 568.69 | 322 / 328 | 78% | 9.37 | 138 / 178 |
uterus | 100% | 1230.72 | 170 / 170 | 69% | 5.41 | 319 / 459 |
brain | 99% | 958.10 | 2617 / 2642 | 68% | 4.33 | 481 / 705 |
thymus | 100% | 1197.40 | 653 / 653 | 65% | 4.04 | 391 / 605 |
adrenal gland | 100% | 1438.72 | 258 / 258 | 29% | 1.98 | 66 / 230 |
adipose | 100% | 1360.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
spleen | 100% | 1079.30 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.37 | 1 / 1 |
blood vessel | 100% | 881.98 | 1333 / 1335 | 0% | 0 | 0 / 0 |
muscle | 100% | 1131.78 | 801 / 803 | 0% | 0 | 0 / 0 |
heart | 94% | 738.46 | 810 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 72% | 524.20 | 666 / 929 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 64% | 5.25 | 29 / 45 |
eye | 0% | 0 | 0 / 0 | 53% | 3.55 | 42 / 80 |
lymph node | 0% | 0 | 0 / 0 | 38% | 2.07 | 11 / 29 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0009134 | Biological process | nucleoside diphosphate catabolic process |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0051084 | Biological process | 'de novo' post-translational protein folding |
GO_0006011 | Biological process | UDP-glucose metabolic process |
GO_0006256 | Biological process | UDP catabolic process |
GO_0005615 | Cellular component | extracellular space |
GO_0005783 | Cellular component | endoplasmic reticulum |
GO_0005576 | Cellular component | extracellular region |
GO_0016020 | Cellular component | membrane |
GO_0004382 | Molecular function | GDP phosphatase activity |
GO_0045134 | Molecular function | UDP phosphatase activity |
GO_0043262 | Molecular function | ADP phosphatase activity |
GO_1990003 | Molecular function | IDP phosphatase activity |
GO_0005515 | Molecular function | protein binding |
GO_0036384 | Molecular function | CDP phosphatase activity |
GO_0017111 | Molecular function | ribonucleoside triphosphate phosphatase activity |
Gene name | ENTPD5 |
Protein name | nucleoside diphosphate phosphatase (EC 3.6.1.6) (Guanosine-diphosphatase ENTPD5) (Uridine-diphosphatase ENTPD5) Nucleoside diphosphate phosphatase ENTPD5 (EC 3.6.1.6) (CD39 antigen-like 4) (ER-UDPase) (Ectonucleoside triphosphate diphosphohydrolase 5) (NTPDase 5) (Guanosine-diphosphatase ENTPD5) (GDPase ENTPD5) (Inosine diphosphate phosphatase ENTPD5) (Nucleoside diphosphatase) (Uridine-diphosphatase ENTPD5) (UDPase ENTPD5) |
Synonyms | PCPH hCG_21714 CD39L4 |
Description | FUNCTION: Hydrolyzes nucleoside diphosphates with a preference for GDP, IDP and UDP compared to ADP and CDP . In the lumen of the endoplasmic reticulum, hydrolyzes UDP that acts as an end-product feedback inhibitor of the UDP-Glc:glycoprotein glucosyltransferases. UMP can be transported back by an UDP-sugar antiporter to the cytosol where it is consumed to regenerate UDP-glucose. Therefore, it positively regulates protein reglucosylation by clearing UDP from the ER lumen and by promoting the regeneration of UDP-glucose. Protein reglucosylation is essential to proper glycoprotein folding and quality control in the ER (By similarity). . |
Accessions | ENST00000555829.5 O75356 ENST00000557325.5 G3V3Y0 H0YJH1 G3V450 ENST00000553284.5 ENST00000334696.11 ENST00000556242.5 G3V4I0 |